0
     

Report Added
Report already added
Global COVID-19 Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global COVID-19 Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

The COVID-19 Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COVID-19 Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global key companies of COVID-19 Drugs include Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, and Zydus Cadila, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
COVID-19 Drugs market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablet
Injection
Market segment by Application, can be divided into
Mild Symptom Patient
Critically Ill Patient
Market segment by players, this report covers
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Bayer
Rising Pharmaceutical
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe COVID-19 Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of COVID-19 Drugs, with recent developments and future plans
Chapter 3, the COVID-19 Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 Drugs market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe COVID-19 Drugs research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of COVID-19 Drugs
1.2 Classification of COVID-19 Drugs by Type
1.2.1 Overview: Global COVID-19 Drugs Market Size by Type: 2022 Versus 2028
1.2.2 Global COVID-19 Drugs Revenue Market Share by Type in 2028
1.2.3 Tablet
1.2.4 Injection
1.3 Global COVID-19 Drugs Market by Application
1.3.1 Overview: Global COVID-19 Drugs Market Size by Application: 2022 Versus 2028
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Global COVID-19 Drugs Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 COVID-19 Drugs Market Drivers
1.5.2 COVID-19 Drugs Market Restraints
1.5.3 COVID-19 Drugs Trends Analysis
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi COVID-19 Drugs Product and Solutions
2.1.4 Sanofi Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis COVID-19 Drugs Product and Solutions
2.2.4 Novartis Recent Developments and Future Plans
2.3 Shanghai Zhongxisanwei
2.3.1 Shanghai Zhongxisanwei Details
2.3.2 Shanghai Zhongxisanwei Major Business
2.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Product and Solutions
2.3.4 Shanghai Zhongxisanwei Recent Developments and Future Plans
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva COVID-19 Drugs Product and Solutions
2.4.4 Teva Recent Developments and Future Plans
2.5 Zydus Cadila
2.5.1 Zydus Cadila Details
2.5.2 Zydus Cadila Major Business
2.5.3 Zydus Cadila COVID-19 Drugs Product and Solutions
2.5.4 Zydus Cadila Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan COVID-19 Drugs Product and Solutions
2.6.4 Mylan Recent Developments and Future Plans
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex COVID-19 Drugs Product and Solutions
2.7.4 Apotex Recent Developments and Future Plans
2.8 Advanz Pharma
2.8.1 Advanz Pharma Details
2.8.2 Advanz Pharma Major Business
2.8.3 Advanz Pharma COVID-19 Drugs Product and Solutions
2.8.4 Advanz Pharma Recent Developments and Future Plans
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma COVID-19 Drugs Product and Solutions
2.9.4 Sun Pharma Recent Developments and Future Plans
2.10 Kyung Poong
2.10.1 Kyung Poong Details
2.10.2 Kyung Poong Major Business
2.10.3 Kyung Poong COVID-19 Drugs Product and Solutions
2.10.4 Kyung Poong Recent Developments and Future Plans
2.11 Ipca Laboratories
2.11.1 Ipca Laboratories Details
2.11.2 Ipca Laboratories Major Business
2.11.3 Ipca Laboratories COVID-19 Drugs Product and Solutions
2.11.4 Ipca Laboratories Recent Developments and Future Plans
2.12 Hanlim Pharmaceutical
2.12.1 Hanlim Pharmaceutical Details
2.12.2 Hanlim Pharmaceutical Major Business
2.12.3 Hanlim Pharmaceutical COVID-19 Drugs Product and Solutions
2.12.4 Hanlim Pharmaceutical Recent Developments and Future Plans
2.13 Bristol Laboratories
2.13.1 Bristol Laboratories Details
2.13.2 Bristol Laboratories Major Business
2.13.3 Bristol Laboratories COVID-19 Drugs Product and Solutions
2.13.4 Bristol Laboratories Recent Developments and Future Plans
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer COVID-19 Drugs Product and Solutions
2.14.4 Bayer Recent Developments and Future Plans
2.15 Rising Pharmaceutical
2.15.1 Rising Pharmaceutical Details
2.15.2 Rising Pharmaceutical Major Business
2.15.3 Rising Pharmaceutical COVID-19 Drugs Product and Solutions
2.15.4 Rising Pharmaceutical Recent Developments and Future Plans
2.16 Shanghai Pharma
2.16.1 Shanghai Pharma Details
2.16.2 Shanghai Pharma Major Business
2.16.3 Shanghai Pharma COVID-19 Drugs Product and Solutions
2.16.4 Shanghai Pharma Recent Developments and Future Plans
2.17 Sichuan Sunny Hope
2.17.1 Sichuan Sunny Hope Details
2.17.2 Sichuan Sunny Hope Major Business
2.17.3 Sichuan Sunny Hope COVID-19 Drugs Product and Solutions
2.17.4 Sichuan Sunny Hope Recent Developments and Future Plans
2.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
2.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details
2.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business
2.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product and Solutions
2.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans
2.19 CSPC Group
2.19.1 CSPC Group Details
2.19.2 CSPC Group Major Business
2.19.3 CSPC Group COVID-19 Drugs Product and Solutions
2.19.4 CSPC Group Recent Developments and Future Plans
2.20 KPC Group
2.20.1 KPC Group Details
2.20.2 KPC Group Major Business
2.20.3 KPC Group COVID-19 Drugs Product and Solutions
2.20.4 KPC Group Recent Developments and Future Plans
2.21 Jinghua Pharmaceutical Group
2.21.1 Jinghua Pharmaceutical Group Details
2.21.2 Jinghua Pharmaceutical Group Major Business
2.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Product and Solutions
2.21.4 Jinghua Pharmaceutical Group Recent Developments and Future Plans
2.22 Zhongsheng Pharma
2.22.1 Zhongsheng Pharma Details
2.22.2 Zhongsheng Pharma Major Business
2.22.3 Zhongsheng Pharma COVID-19 Drugs Product and Solutions
2.22.4 Zhongsheng Pharma Recent Developments and Future Plans
2.23 North China Pharmaceutical Group
2.23.1 North China Pharmaceutical Group Details
2.23.2 North China Pharmaceutical Group Major Business
2.23.3 North China Pharmaceutical Group COVID-19 Drugs Product and Solutions
2.23.4 North China Pharmaceutical Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global COVID-19 Drugs Revenue and Share by Players (2022 & 2028)
3.2 COVID-19 Drugs Players Head Office, Products and Services Provided
3.3 COVID-19 Drugs Mergers & Acquisitions
3.4 COVID-19 Drugs New Entrants and Expansion Plans
4 Global COVID-19 Drugs Forecast by Region
4.1 Global COVID-19 Drugs Market Size by Region: 2022 VS 2028
4.2 Global COVID-19 Drugs Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of COVID-19 Drugs in North America
4.3.2 Current Situation and Forecast of COVID-19 Drugs in North America
4.3.3 North America COVID-19 Drugs Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of COVID-19 Drugs in Europe
4.4.2 Current Situation and Forecast of COVID-19 Drugs in Europe
4.4.3 Europe COVID-19 Drugs Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of COVID-19 Drugs in Asia-Pacific
4.5.2 Current Situation and Forecast of COVID-19 Drugs in Asia-Pacific
4.5.3 Asia-Pacific COVID-19 Drugs Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of COVID-19 Drugs in South America
4.6.2 Current Situation and Forecast of COVID-19 Drugs in South America
4.6.3 South America COVID-19 Drugs Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of COVID-19 Drugs in Middle East & Africa
4.7.2 Current Situation and Forecast of COVID-19 Drugs in Middle East & Africa
4.7.3 Middle East & Africa COVID-19 Drugs Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
5.1 Global COVID-19 Drugs Market Forecast by Type (2022-2028)
5.2 Global COVID-19 Drugs Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
6.1 Global COVID-19 Drugs Market Forecast by Application (2022-2028)
6.2 Global COVID-19 Drugs Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List of Tables
Table 1. Global COVID-19 Drugs Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global COVID-19 Drugs Revenue by Application, (USD Million), 2022 VS 2028
Table 3. Sanofi Corporate Information, Head Office, and Major Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi COVID-19 Drugs Product and Solutions
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis COVID-19 Drugs Product and Solutions
Table 9. Shanghai Zhongxisanwei Corporate Information, Head Office, and Major Competitors
Table 10. Shanghai Zhongxisanwei Major Business
Table 11. Shanghai Zhongxisanwei COVID-19 Drugs Product and Solutions
Table 12. Teva Corporate Information, Head Office, and Major Competitors
Table 13. Teva Major Business
Table 14. Teva COVID-19 Drugs Product and Solutions
Table 15. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 16. Zydus Cadila Major Business
Table 17. Zydus Cadila COVID-19 Drugs Product and Solutions
Table 18. Mylan Corporate Information, Head Office, and Major Competitors
Table 19. Mylan Major Business
Table 20. Mylan COVID-19 Drugs Product and Solutions
Table 21. Apotex Corporate Information, Head Office, and Major Competitors
Table 22. Apotex Major Business
Table 23. Apotex COVID-19 Drugs Product and Solutions
Table 24. Advanz Pharma Corporate Information, Head Office, and Major Competitors
Table 25. Advanz Pharma Major Business
Table 26. Advanz Pharma COVID-19 Drugs Product and Solutions
Table 27. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 28. Sun Pharma Major Business
Table 29. Sun Pharma COVID-19 Drugs Product and Solutions
Table 30. Kyung Poong Corporate Information, Head Office, and Major Competitors
Table 31. Kyung Poong Major Business
Table 32. Kyung Poong COVID-19 Drugs Product and Solutions
Table 33. Ipca Laboratories Corporate Information, Head Office, and Major Competitors
Table 34. Ipca Laboratories Major Business
Table 35. Ipca Laboratories COVID-19 Drugs Product and Solutions
Table 36. Hanlim Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 37. Hanlim Pharmaceutical Major Business
Table 38. Hanlim Pharmaceutical COVID-19 Drugs Product and Solutions
Table 39. Bristol Laboratories Corporate Information, Head Office, and Major Competitors
Table 40. Bristol Laboratories Major Business
Table 41. Bristol Laboratories COVID-19 Drugs Product and Solutions
Table 42. Bayer Corporate Information, Head Office, and Major Competitors
Table 43. Bayer Major Business
Table 44. Bayer COVID-19 Drugs Product and Solutions
Table 45. Rising Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 46. Rising Pharmaceutical Major Business
Table 47. Rising Pharmaceutical COVID-19 Drugs Product and Solutions
Table 48. Shanghai Pharma Corporate Information, Head Office, and Major Competitors
Table 49. Shanghai Pharma Major Business
Table 50. Shanghai Pharma COVID-19 Drugs Product and Solutions
Table 51. Sichuan Sunny Hope Corporate Information, Head Office, and Major Competitors
Table 52. Sichuan Sunny Hope Major Business
Table 53. Sichuan Sunny Hope COVID-19 Drugs Product and Solutions
Table 54. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 55. Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business
Table 56. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product and Solutions
Table 57. CSPC Group Corporate Information, Head Office, and Major Competitors
Table 58. CSPC Group Major Business
Table 59. CSPC Group COVID-19 Drugs Product and Solutions
Table 60. KPC Group Corporate Information, Head Office, and Major Competitors
Table 61. KPC Group Major Business
Table 62. KPC Group COVID-19 Drugs Product and Solutions
Table 63. Jinghua Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
Table 64. Jinghua Pharmaceutical Group Major Business
Table 65. Jinghua Pharmaceutical Group COVID-19 Drugs Product and Solutions
Table 66. Zhongsheng Pharma Corporate Information, Head Office, and Major Competitors
Table 67. Zhongsheng Pharma Major Business
Table 68. Zhongsheng Pharma COVID-19 Drugs Product and Solutions
Table 69. North China Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
Table 70. North China Pharmaceutical Group Major Business
Table 71. North China Pharmaceutical Group COVID-19 Drugs Product and Solutions
Table 72. Global COVID-19 Drugs Revenue (USD Million) by Players (2022 & 2028)
Table 73. Global COVID-19 Drugs Revenue Share by Players (2022 & 2028)
Table 74. COVID-19 Drugs Players Head Office, Products and Services Provided
Table 75. COVID-19 Drugs Mergers & Acquisitions in the Past Five Years
Table 76. COVID-19 Drugs New Entrants and Expansion Plans
Table 77. Global Market COVID-19 Drugs Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 78. Global COVID-19 Drugs Revenue Market Share by Region (2022-2028)
Table 79. Key Companies of COVID-19 Drugs in North America
Table 80. Current Situation and Forecast of COVID-19 Drugs in North America
Table 81. Key Companies of COVID-19 Drugs in Europe
Table 82. Current Situation and Forecast of COVID-19 Drugs in Europe
Table 83. Key Companies of COVID-19 Drugs in Asia-Pacific
Table 84. Current Situation and Forecast of COVID-19 Drugs in Asia-Pacific
Table 85. Key Companies of COVID-19 Drugs in China
Table 86. Key Companies of COVID-19 Drugs in Japan
Table 87. Key Companies of COVID-19 Drugs in South Korea
Table 88. Key Companies of COVID-19 Drugs in South America
Table 89. Current Situation and Forecast of COVID-19 Drugs in South America
Table 90. Key Companies of COVID-19 Drugs in Middle East & Africa
Table 91. Current Situation and Forecast of COVID-19 Drugs in Middle East & Africa
Table 92. Global COVID-19 Drugs Revenue Forecast by Type (2022-2028)
Table 93. Global COVID-19 Drugs Revenue Forecast by Application (2022-2028)

List of Figures
Figure 1. COVID-19 Drugs Picture
Figure 2. Global COVID-19 Drugs Revenue Market Share by Type in 2028
Figure 3. Tablet
Figure 4. Injection
Figure 5. COVID-19 Drugs Revenue Market Share by Application in 2028
Figure 6. Mild Symptom Patient Picture
Figure 7. Critically Ill Patient Picture
Figure 8. Global COVID-19 Drugs Market Size, (USD Million): 2022 VS 2028
Figure 9. Global COVID-19 Drugs Revenue and Forecast (2022-2028) & (USD Million)
Figure 10. COVID-19 Drugs Market Drivers
Figure 11. COVID-19 Drugs Market Restraints
Figure 12. COVID-19 Drugs Market Trends
Figure 13. Sanofi Recent Developments and Future Plans
Figure 14. Novartis Recent Developments and Future Plans
Figure 15. Shanghai Zhongxisanwei Recent Developments and Future Plans
Figure 16. Teva Recent Developments and Future Plans
Figure 17. Zydus Cadila Recent Developments and Future Plans
Figure 18. Mylan Recent Developments and Future Plans
Figure 19. Apotex Recent Developments and Future Plans
Figure 20. Advanz Pharma Recent Developments and Future Plans
Figure 21. Sun Pharma Recent Developments and Future Plans
Figure 22. Kyung Poong Recent Developments and Future Plans
Figure 23. Ipca Laboratories Recent Developments and Future Plans
Figure 24. Hanlim Pharmaceutical Recent Developments and Future Plans
Figure 25. Bristol Laboratories Recent Developments and Future Plans
Figure 26. Bayer Recent Developments and Future Plans
Figure 27. Rising Pharmaceutical Recent Developments and Future Plans
Figure 28. Shanghai Pharma Recent Developments and Future Plans
Figure 29. Sichuan Sunny Hope Recent Developments and Future Plans
Figure 30. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans
Figure 31. CSPC Group Recent Developments and Future Plans
Figure 32. KPC Group Recent Developments and Future Plans
Figure 33. Jinghua Pharmaceutical Group Recent Developments and Future Plans
Figure 34. Zhongsheng Pharma Recent Developments and Future Plans
Figure 35. North China Pharmaceutical Group Recent Developments and Future Plans
Figure 36. Global COVID-19 Drugs Revenue Market Share by Region (2022-2028)
Figure 37. Global COVID-19 Drugs Revenue Market Share by Region in 2028
Figure 38. North America COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)
Figure 39. Europe COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)
Figure 40. Asia-Pacific COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)
Figure 41. South America COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)
Figure 42. Middle East & Africa COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)
Figure 43. Global COVID-19 Drugs Market Share Forecast by Type (2022-2028)
Figure 44. Global COVID-19 Drugs Market Share Forecast by Application (2022-2028)
Figure 45. Methodology
Figure 46. Research Process and Data Source

Report Title: Global COVID-19 Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW